Concepts (162)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Neoplasms | 12 | 2025 | 1782 | 1.970 |
Why?
|
| Genome-Wide Association Study | 14 | 2025 | 1868 | 1.960 |
Why?
|
| Genetic Predisposition to Disease | 11 | 2025 | 3479 | 1.360 |
Why?
|
| Multifactorial Inheritance | 4 | 2025 | 162 | 1.210 |
Why?
|
| Linkage Disequilibrium | 5 | 2024 | 333 | 1.010 |
Why?
|
| Periodontitis | 1 | 2022 | 18 | 0.760 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2025 | 872 | 0.750 |
Why?
|
| Exosomes | 1 | 2022 | 56 | 0.720 |
Why?
|
| Saliva | 1 | 2022 | 133 | 0.710 |
Why?
|
| Hepatic Stellate Cells | 4 | 2024 | 26 | 0.580 |
Why?
|
| Toll-Like Receptor 3 | 1 | 2018 | 22 | 0.570 |
Why?
|
| Polymorphism, Single Nucleotide | 12 | 2025 | 2936 | 0.560 |
Why?
|
| Insulin Resistance | 1 | 2022 | 696 | 0.510 |
Why?
|
| Liver | 4 | 2018 | 1878 | 0.510 |
Why?
|
| Inflammation | 3 | 2020 | 1591 | 0.510 |
Why?
|
| Fatty Liver | 1 | 2018 | 215 | 0.490 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2025 | 1415 | 0.470 |
Why?
|
| MicroRNAs | 1 | 2022 | 950 | 0.450 |
Why?
|
| Smoking | 6 | 2025 | 1136 | 0.420 |
Why?
|
| CX3C Chemokine Receptor 1 | 2 | 2024 | 13 | 0.380 |
Why?
|
| Genes, Essential | 1 | 2009 | 43 | 0.320 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2014 | 2121 | 0.300 |
Why?
|
| Mendelian Randomization Analysis | 3 | 2023 | 96 | 0.280 |
Why?
|
| Prostatic Neoplasms | 4 | 2012 | 1623 | 0.280 |
Why?
|
| Macrophages | 2 | 2024 | 703 | 0.270 |
Why?
|
| Humans | 32 | 2025 | 133705 | 0.250 |
Why?
|
| Monocytes | 2 | 2018 | 360 | 0.240 |
Why?
|
| Liver Neoplasms | 3 | 2025 | 1410 | 0.240 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2024 | 1000 | 0.230 |
Why?
|
| Male | 20 | 2025 | 65850 | 0.230 |
Why?
|
| Quantitative Trait Loci | 2 | 2025 | 318 | 0.220 |
Why?
|
| Myositis | 1 | 2025 | 102 | 0.210 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2016 | 247 | 0.210 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2025 | 326 | 0.210 |
Why?
|
| Diabetic Ketoacidosis | 1 | 2025 | 169 | 0.210 |
Why?
|
| Research Personnel | 1 | 2024 | 135 | 0.210 |
Why?
|
| Hyperglycemia | 1 | 2025 | 242 | 0.210 |
Why?
|
| Population Health | 1 | 2023 | 41 | 0.200 |
Why?
|
| Phenotype | 6 | 2024 | 4551 | 0.200 |
Why?
|
| Amino Acids | 1 | 2025 | 687 | 0.200 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2025 | 213 | 0.190 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2023 | 73 | 0.190 |
Why?
|
| Patient Acuity | 1 | 2022 | 67 | 0.190 |
Why?
|
| Risk Factors | 5 | 2025 | 11112 | 0.190 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2024 | 445 | 0.180 |
Why?
|
| Kupffer Cells | 2 | 2018 | 22 | 0.180 |
Why?
|
| Crohn Disease | 1 | 2024 | 286 | 0.180 |
Why?
|
| Female | 13 | 2025 | 71603 | 0.170 |
Why?
|
| Dyspnea | 1 | 2022 | 160 | 0.170 |
Why?
|
| Growth Differentiation Factor 15 | 1 | 2020 | 29 | 0.170 |
Why?
|
| Regression Analysis | 1 | 2022 | 826 | 0.160 |
Why?
|
| Aged | 5 | 2025 | 21674 | 0.160 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 377 | 0.160 |
Why?
|
| Middle Aged | 6 | 2025 | 29293 | 0.160 |
Why?
|
| Esophageal Neoplasms | 1 | 2024 | 393 | 0.160 |
Why?
|
| Case-Control Studies | 5 | 2025 | 3649 | 0.150 |
Why?
|
| Thoracic Surgery | 1 | 2021 | 163 | 0.150 |
Why?
|
| United States | 5 | 2025 | 11709 | 0.150 |
Why?
|
| Body Mass Index | 2 | 2022 | 1713 | 0.150 |
Why?
|
| Receptors, Cannabinoid | 1 | 2018 | 10 | 0.150 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2025 | 904 | 0.140 |
Why?
|
| Carcinogenesis | 1 | 2021 | 363 | 0.140 |
Why?
|
| Mice | 6 | 2024 | 18948 | 0.140 |
Why?
|
| Vitamin A | 2 | 2015 | 61 | 0.140 |
Why?
|
| Genetic Testing | 1 | 2025 | 1094 | 0.140 |
Why?
|
| RNA-Binding Proteins | 1 | 2022 | 614 | 0.140 |
Why?
|
| Endocannabinoids | 1 | 2018 | 44 | 0.140 |
Why?
|
| Mice, Knockout | 4 | 2020 | 3991 | 0.140 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2025 | 870 | 0.130 |
Why?
|
| Adenocarcinoma | 1 | 2024 | 1070 | 0.130 |
Why?
|
| Kidney Diseases | 1 | 2021 | 505 | 0.130 |
Why?
|
| Granulocytes | 1 | 2016 | 70 | 0.130 |
Why?
|
| Glioma | 1 | 2021 | 538 | 0.130 |
Why?
|
| Hepatocytes | 1 | 2018 | 241 | 0.130 |
Why?
|
| Diet, High-Fat | 1 | 2018 | 237 | 0.130 |
Why?
|
| Concanavalin A | 1 | 2015 | 16 | 0.120 |
Why?
|
| Animals | 8 | 2024 | 36421 | 0.120 |
Why?
|
| Immunophenotyping | 1 | 2016 | 342 | 0.120 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2016 | 152 | 0.120 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2015 | 117 | 0.110 |
Why?
|
| Biomarkers | 2 | 2025 | 3430 | 0.110 |
Why?
|
| DNA-Binding Proteins | 1 | 2022 | 2164 | 0.110 |
Why?
|
| Cell Differentiation | 2 | 2018 | 2025 | 0.100 |
Why?
|
| Adult | 6 | 2025 | 31872 | 0.100 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 936 | 0.100 |
Why?
|
| Interferon-gamma | 2 | 2015 | 538 | 0.100 |
Why?
|
| United Kingdom | 2 | 2024 | 238 | 0.100 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2021 | 1159 | 0.100 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2014 | 1071 | 0.090 |
Why?
|
| Heart Defects, Congenital | 1 | 2021 | 1874 | 0.080 |
Why?
|
| Killer Cells, Natural | 1 | 2011 | 355 | 0.070 |
Why?
|
| Immunity, Innate | 1 | 2011 | 416 | 0.070 |
Why?
|
| Neoplasms | 2 | 2014 | 3028 | 0.070 |
Why?
|
| Genome, Human | 2 | 2014 | 1348 | 0.070 |
Why?
|
| Neoplasm Metastasis | 2 | 2025 | 745 | 0.060 |
Why?
|
| Genomics | 1 | 2014 | 1672 | 0.060 |
Why?
|
| Genetic Variation | 1 | 2012 | 1621 | 0.060 |
Why?
|
| Chemokine CX3CL1 | 1 | 2024 | 4 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 3 | 2020 | 4841 | 0.060 |
Why?
|
| Arginase | 1 | 2024 | 35 | 0.060 |
Why?
|
| Smokers | 1 | 2024 | 45 | 0.050 |
Why?
|
| Liver Cirrhosis | 1 | 2011 | 935 | 0.050 |
Why?
|
| Cell Communication | 1 | 2024 | 187 | 0.050 |
Why?
|
| North America | 1 | 2024 | 260 | 0.050 |
Why?
|
| Interferon Regulatory Factors | 1 | 2023 | 41 | 0.050 |
Why?
|
| Genetic Loci | 1 | 2024 | 366 | 0.050 |
Why?
|
| Metabolomics | 1 | 2025 | 456 | 0.050 |
Why?
|
| International Agencies | 1 | 2021 | 31 | 0.050 |
Why?
|
| Colitis, Ulcerative | 1 | 2024 | 217 | 0.050 |
Why?
|
| Risk | 1 | 2023 | 834 | 0.040 |
Why?
|
| Education | 1 | 2021 | 112 | 0.040 |
Why?
|
| Morbidity | 1 | 2021 | 256 | 0.040 |
Why?
|
| Chromosome Aberrations | 1 | 2023 | 626 | 0.040 |
Why?
|
| Gene Expression Profiling | 3 | 2012 | 1917 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2025 | 1973 | 0.040 |
Why?
|
| Communicable Disease Control | 1 | 2021 | 143 | 0.040 |
Why?
|
| Research Design | 1 | 2024 | 746 | 0.040 |
Why?
|
| Computational Biology | 1 | 2024 | 887 | 0.040 |
Why?
|
| Databases, Genetic | 1 | 2021 | 500 | 0.040 |
Why?
|
| Alcohol Drinking | 1 | 2021 | 387 | 0.040 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2018 | 109 | 0.040 |
Why?
|
| Life Style | 1 | 2021 | 458 | 0.040 |
Why?
|
| Comorbidity | 1 | 2023 | 1621 | 0.040 |
Why?
|
| Spleen | 1 | 2018 | 291 | 0.030 |
Why?
|
| Ethanol | 1 | 2018 | 170 | 0.030 |
Why?
|
| Phagocytes | 1 | 2016 | 25 | 0.030 |
Why?
|
| Mice, Obese | 1 | 2016 | 74 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2018 | 452 | 0.030 |
Why?
|
| Hospitals, Pediatric | 1 | 2021 | 788 | 0.030 |
Why?
|
| Alcohol Dehydrogenase | 1 | 2015 | 23 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2018 | 905 | 0.030 |
Why?
|
| Tretinoin | 1 | 2015 | 118 | 0.030 |
Why?
|
| Chemokine CCL2 | 1 | 2015 | 134 | 0.030 |
Why?
|
| Length of Stay | 1 | 2021 | 1387 | 0.030 |
Why?
|
| Age Factors | 1 | 2021 | 2989 | 0.030 |
Why?
|
| Lung | 1 | 2022 | 1558 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 3743 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2023 | 5194 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2015 | 450 | 0.030 |
Why?
|
| Models, Biological | 1 | 2018 | 1535 | 0.030 |
Why?
|
| Cell Survival | 1 | 2015 | 889 | 0.030 |
Why?
|
| Pyrazoles | 1 | 2015 | 329 | 0.030 |
Why?
|
| Aging | 1 | 2020 | 1301 | 0.020 |
Why?
|
| Cell Movement | 1 | 2015 | 917 | 0.020 |
Why?
|
| Carbon Tetrachloride Poisoning | 1 | 2011 | 3 | 0.020 |
Why?
|
| Suppressor of Cytokine Signaling 1 Protein | 1 | 2011 | 10 | 0.020 |
Why?
|
| Poly I-C | 1 | 2011 | 26 | 0.020 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2011 | 25 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2012 | 440 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2021 | 3991 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2014 | 701 | 0.020 |
Why?
|
| Cytokines | 1 | 2016 | 1396 | 0.020 |
Why?
|
| Mutation | 1 | 2024 | 6294 | 0.020 |
Why?
|
| Logistic Models | 1 | 2014 | 1908 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2021 | 3167 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2011 | 484 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2010 | 505 | 0.020 |
Why?
|
| Bone Neoplasms | 1 | 2010 | 446 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2012 | 1717 | 0.010 |
Why?
|
| Algorithms | 1 | 2010 | 1733 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2021 | 17421 | 0.010 |
Why?
|
| Child | 1 | 2021 | 25765 | 0.010 |
Why?
|